# Vor Biopharma Inc.: filings

VOR · Nasdaq · CIK 1817229 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vor.md) · [Financials](/companies/vor/financials.md) · [Filings](/companies/vor/filings.md) · [Insiders](/companies/vor/insiders.md)

## Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 179, 8-K 48, 3 32, SCHEDULE 13D/A 24, 144 22, 10-Q 18, SCHEDULE 13G/A 17, CORRESP 11, SCHEDULE 13G 10, UPLOAD 10, S-8 8, EFFECT 7, S-3 7, 10-K 6, 424B5 6, DEF 14A 6, DEFA14A 6, SC 13G/A 6, ARS 4, SC 13D/A 4, 424B3 3, PRE 14A 2, S-1/A 2, SC 13D 2, SC 13G 2, SCHEDULE 13D 2, SEC STAFF LETTER 2, 10-Q/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DEFR14A 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, S-1 1, S-1MEF 1, S-3/A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 08:01 ET | [10-Q](/filings/0001193125-26-439905.md) | Quarterly report, period 2026-09-30 | 0001193125-26-439905 |
| 2026-08-11 | 09:30 ET | [10-Q](/filings/0001193125-26-343607.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343607 |
| 2026-07-21 | 16:55 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000197.md) | Ownership report, active investor, amended | 0001346824-26-000197 |
| 2026-07-07 | 16:04 ET | [8-K](/filings/0001193125-26-297454.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-297454 |
| 2026-06-12 | 16:11 ET | [8-K](/filings/0001193125-26-269431.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269431 |
| 2026-06-08 | 16:01 ET | [8-K](/filings/0001193125-26-261661.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-261661 |
| 2026-05-13 | 08:31 ET | [10-Q](/filings/0001193125-26-220689.md) | Quarterly report, period 2026-03-31 | 0001193125-26-220689 |
| 2026-04-27 | 16:00 ET | [DEF 14A](/filings/0001193125-26-181883.md) | Proxy statement, period 2026-04-23 | 0001193125-26-181883 |
| 2026-04-21 | 19:05 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000113.md) | Ownership report, active investor, amended | 0001346824-26-000113 |
| 2026-04-15 | 17:31 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000107.md) | Ownership report, active investor, amended | 0001346824-26-000107 |
| 2026-04-10 | 18:25 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000103.md) | Ownership report, active investor, amended | 0001346824-26-000103 |
| 2026-04-08 | 18:45 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000101.md) | Ownership report, active investor, amended | 0001346824-26-000101 |
| 2026-04-01 | 17:09 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000090.md) | Ownership report, active investor, amended | 0001346824-26-000090 |
| 2026-03-30 | 08:03 ET | [10-K](/filings/0001193125-26-130451.md) | Annual report, period 2025-12-31 | 0001193125-26-130451 |
| 2026-03-27 | 08:03 ET | [8-K](/filings/0001193125-26-127609.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-127609 |
| 2026-03-16 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-028470.md) | Ownership report, active investor, amended | 0001104659-26-028470 |
| 2026-01-12 | 09:55 ET | [8-K](/filings/0001193125-26-009961.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009961 |
| 2026-01-02 | 16:01 ET | [8-K](/filings/0001193125-26-000905.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-000905 |
| 2025-12-23 | 16:05 ET | [SCHEDULE 13D](/filings/0001193125-25-330843.md) | Ownership report, active investor | 0001193125-25-330843 |
| 2025-12-18 | 18:31 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000081.md) | Ownership report, active investor, amended | 0001346824-25-000081 |
| 2025-12-18 | 16:00 ET | [8-K](/filings/0001193125-25-324768.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-324768 |
| 2025-12-09 | 07:58 ET | [8-K](/filings/0001193125-25-311957.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-311957 |
| 2025-11-14 | 18:13 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000059.md) | Ownership report, active investor, amended | 0001346824-25-000059 |
| 2025-11-13 | 16:02 ET | [10-Q](/filings/0001193125-25-280104.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280104 |
| 2025-11-12 | 07:03 ET | [8-K](/filings/0001193125-25-275862.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-275862 |
| 2025-11-03 | 08:02 ET | [8-K](/filings/0001193125-25-261723.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-261723 |
| 2025-10-30 | 18:42 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000033.md) | Ownership report, active investor, amended | 0001346824-25-000033 |
| 2025-10-28 | 16:37 ET | [8-K](/filings/0001193125-25-253636.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-253636 |
| 2025-10-27 | 20:06 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000029.md) | Ownership report, active investor, amended | 0001346824-25-000029 |
| 2025-10-20 | 18:58 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000022.md) | Ownership report, active investor, amended | 0001346824-25-000022 |
| 2025-10-17 | 18:36 ET | [SCHEDULE 13D/A](/filings/0002050755-25-000018.md) | Ownership report, active investor, amended | 0002050755-25-000018 |
| 2025-10-16 | 16:45 ET | [SCHEDULE 13D/A](/filings/0002050755-25-000016.md) | Ownership report, active investor, amended | 0002050755-25-000016 |
| 2025-10-10 | 17:52 ET | [SCHEDULE 13D/A](/filings/0002050755-25-000014.md) | Ownership report, active investor, amended | 0002050755-25-000014 |
| 2025-10-08 | 17:24 ET | [SCHEDULE 13D/A](/filings/0002050755-25-000012.md) | Ownership report, active investor, amended | 0002050755-25-000012 |
| 2025-10-06 | 17:20 ET | [SCHEDULE 13D/A](/filings/0002050755-25-000010.md) | Ownership report, active investor, amended | 0002050755-25-000010 |
| 2025-09-19 | 16:53 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000007.md) | Ownership report, active investor, amended | 0001346824-25-000007 |
| 2025-09-17 | 09:00 ET | [8-K](/filings/0001193125-25-205553.md) | 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-205553 |
| 2025-09-12 | 19:07 ET | [SCHEDULE 13D/A](/filings/0001415889-25-024456.md) | Ownership report, active investor, amended | 0001415889-25-024456 |
| 2025-09-09 | 18:04 ET | [SCHEDULE 13D/A](/filings/0001415889-25-023998.md) | Ownership report, active investor, amended | 0001415889-25-023998 |
| 2025-09-02 | 10:43 ET | [8-K](/filings/0001193125-25-193600.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-193600 |
| 2025-08-29 | 18:30 ET | [SCHEDULE 13D/A](/filings/0001415889-25-023320.md) | Ownership report, active investor, amended | 0001415889-25-023320 |
| 2025-08-27 | 12:34 ET | [8-K](/filings/0001193125-25-189435.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-189435 |
| 2025-08-27 | 08:19 ET | [8-K](/filings/0001193125-25-189169.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-189169 |
| 2025-08-12 | 16:02 ET | [10-Q](/filings/0000950170-25-107276.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107276 |
| 2025-08-08 | 08:55 ET | [DEF 14A](/filings/0001140361-25-029749.md) | Proxy statement, period 2025-08-25 | 0001140361-25-029749 |
| 2025-07-22 | 17:01 ET | [8-K](/filings/0001193125-25-162644.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-162644 |
| 2025-07-10 | 16:45 ET | [8-K](/filings/0001193125-25-157638.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157638 |
| 2025-07-09 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001415889-25-019583.md) | Ownership report, active investor, amended | 0001415889-25-019583 |
| 2025-06-27 | 16:16 ET | [SCHEDULE 13D/A](/filings/0001415889-25-018378.md) | Ownership report, active investor, amended | 0001415889-25-018378 |
| 2025-06-26 | 21:18 ET | [8-K](/filings/0001193125-25-147339.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-147339 |

Page 1 of 3. [Older](/companies/vor/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 03:06 ET. No prices; not investment advice.